The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The price of Ocular Therapeutix Inc (NASDAQ: OCUL) closed at $9.35 in the last session, down -2.81% from day before closing price of $9.62. In other words, the price has decreased by -$2.81 from its previous closing price. On the day, 0.57 million shares were traded. OCUL stock price reached its highest trading level at $9.8 during the session, while it also had its lowest trading level at $9.12.
Ratios:
We take a closer look at OCUL’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 12.94 and its Current Ratio is at 13.01. In the meantime, Its Debt-to-Equity ratio is 0.21 whereas as Long-Term Debt/Eq ratio is at 0.21.
On June 20, 2024, TD Cowen Upgraded its rating to Buy which previously was Hold and also upped its target price recommendation from $7 to $11.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Nov 25 ’24 when Heier Jeffrey S. sold 2,948 shares for $9.01 per share. The transaction valued at 26,561 led to the insider holds 269,059 shares of the business.
Kaiser Peter sold 2,897 shares of OCUL for $26,102 on Nov 25 ’24. The Chief Development Officer now owns 213,087 shares after completing the transaction at $9.01 per share. On Nov 25 ’24, another insider, Nayak Sanjay, who serves as the Chief Strategy Officer of the company, sold 1,814 shares for $9.00 each. As a result, the insider received 16,326 and left with 174,380 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, OCUL now has a Market Capitalization of 1469978880 and an Enterprise Value of 1161941120. For the stock, the TTM Price-to-Sale (P/S) ratio is 25.07 while its Price-to-Book (P/B) ratio in mrq is 4.16. Its current Enterprise Value per Revenue stands at 19.018 whereas that against EBITDA is -10.492.
Stock Price History:
Over the past 52 weeks, OCUL has reached a high of $11.77, while it has fallen to a 52-week low of $3.24. The 50-Day Moving Average of the stock is -6.94%, while the 200-Day Moving Average is calculated to be 13.56%.
Shares Statistics:
According to the various share statistics, OCUL traded on average about 1.17M shares per day over the past 3-months and 991530 shares per day over the past 10 days. A total of 156.65M shares are outstanding, with a floating share count of 135.46M. Insiders hold about 13.84% of the company’s shares, while institutions hold 77.39% stake in the company. Shares short for OCUL as of 1730332800 were 12671361 with a Short Ratio of 9.17, compared to 1727654400 on 16194368. Therefore, it implies a Short% of Shares Outstanding of 12671361 and a Short% of Float of 8.1599995.
